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CPAPAbstract Obstructive sleep apnea (OSA) is increasingly prevalent worldwide and is associated with
morbidity and mortality, the main line of treatment is CPAP but the compliance is doubtful, as obesity
is highly linked to OSA weight loss can help in treatment. The aim of the present study: was to assess
the effect of bariatric surgery on severe obstructive sleep apnea patients not tolerating CPAP
therapy. Patients and methods: the study was done on 22 patients documented to have morbid
obesity (BMI > 40) and severe OSA with Apnea Hypopnea Index (AHI) >30/h and not tolerating
CPAP therapy, patients were offered sleeve gastrectomy then were followed up for 12 months
before another polysomnography was done to assess the presence of OSA and need for CPAP.
Results: 22 patients completed the study. The mean age of the patients was 37.2 ± 17.3 years,
13 males and 9 females. After sleeve gastrectomy and follow up for 12 months the body weight
decreased from 135.6 ± 17.8 to 101.3 ± 7.6 kg m (p= 0.001), BMI dropped from 48.2 ± 7.3 to
35.9 ± 4.8 kg m/m2 (p= 0.001), mean AHI decreased from 55.8 ± 8.3 to 12.8 ± 11.3 attacks/hour
of sleep (p= 0.001) and CPAP pressure needed to control OSA was decreased from 13.2 ± 2.3 to
8.2 ± 3.9 cm H2O (p= 0.001). Conclusion: sleeve gastrectomy can be an alternate option of
treatment for severe OSA patients who are not tolerating CPAP and surgery may cure the disease
or at least improve compliance to CPAP by decreasing the needed pressure to control OSA.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
OSA is increasingly prevalent, in both adults and children, in
modern society. The estimated prevalence has been 2% for
women and 4% for men. More recent research indicates a
prevalence of 4% for women and 9% for men. Data from
the Wisconsin Cohort Study indicate that the prevalence of
662 H. Shaarawy et al.OSA in people aged 30–60 years is 9–24% for men and 4–9%
for women [1,2]. A recent study examining the association
between OSA and mortality using portable sleep studies on
more than 77,000 patients found that OSA was associated with
all-cause mortality in patients younger than 50 years of age.
While this is a general conclusion from the study, other vari-
ables played a substantial role in mediating this relationship.
These data are consistent with earlier data showing that the
negative impact of OSA on health is more profound in
younger patients [3–6]. Currently, the treatment of choice for
OSA is nasal continuous positive airway pressure (CPAP)
[7]. Despite the documented efﬁcacy of CPAP, it has been
estimated that more than 50% of those patients started on
CPAP will not be using it 1 year later [8]. Because obesity is
a major predictive factor for OSA, weight reduction reduces
the risk of OSA. The best data suggest that a 10% reduction
in weight leads to a 26% reduction in the respiratory distur-
bance index (RDI). Beneﬁts of weight reduction in patients
with sleep disordered breathing SDB include the following:
decreased RDI, lowered blood pressure, improved pulmonary
function and arterial blood gas values, improved sleep
structure and snoring, possible reduction in optimum CPAP
pressure required [9–11]. In this respect bariatric surgery as
therapy for OSA has been investigated in several nonrandom-
ized, uncontrolled studies, with most showing a decrease in the
AHI with weight loss. The 2006 practice parameter on medical
therapies for OSAHS lists bariatric surgery as an option for
OSA, although with limited evidence [12]. In a position paper
on the treatment of OSA, the American Academy of Sleep
Medicine (AASM) stated that bariatric surgery should be
considered as an adjunct to less invasive and rapidly active
ﬁrst-line therapies such as positive airway pressure for patients
who have OSA and meet the currently published guidelines for
bariatric surgery (Consensus). The remission rate for OSA two
years after bariatric surgery, related to the amount of weight
lost, is 40%, emphasizing the need for ongoing clinical
follow-up of these patients [13].
Aim of the work
The aim of the present study is to assess the effect of bariatric
surgery on severe obstructive sleep apnea patients not tolerat-
ing the CPAP therapy.
Patients
The study is a prospective single center observational study; it
was done in the pulmonary rehabilitation center in association
with the surgical department in Al-Amiri hospital, Ministry of
Health, State of Kuwait in the period between June 2013 and
July 2015.
Patients were selected from those following up in sleep dis-
orders clinic of the pulmonary rehabilitation center according
to the following criteria:
1. Age: 18–55 years.
2. Patients proved to have severe obstructive sleep apnea
(OSA) documented with polysomnography with Apnea
Hypopnea Index (AHI) more than 30/hour of sleep.3. Body mass index more than 40 kg/m2.
4. Attempt of losing weight was tried 2 times or more but
failed.
5. Patients not tolerating CPAP therapy with documented
compliance less than 4 h/night.
6. Patients must have no contraindication for surgery due to
other co-morbidities.
7. Written consent was taken from all patients before
indulging in the study.Methods
All patients were subjected to the following:
1. History taking.
2. Complete physical examination.
3. Epworth Sleepiness Scale [14].
4. Body mass index derived from the weight and height
formula (BMI =Wt in kg m/length in m2) [15].
5. Neck circumference.
6. Pulmonary function testing.
7. Arterial blood gases to make sure that the patient is not
having obesity hypoventilation syndrome or any chronic
respiratory disease.
8. Chest X-ray.
9. ECG.
10. Pre-operative full night polysomnography using Alice 5
(Respironics) device including the following channels:
electroencephalogram, electrooculogram, electromyo-
gram, measurement of thoracic and abdominal move-
ments, air ﬂow detection, detection of intensity of
snoring with pressure sensor, pulse oximetry to detect
oxygen saturation and heart rate, position detection.
According to polysomnography AHI was graded as
mild if between 5 and 14 attacks/hour of sleep, moderate
if between 15 and 30 attacks/hour of sleep, and severe if
above 30/hour of sleep and the patient was included in
the study only if having severe OSA.
11. Pre-operative surgical assessment was done to assess for
ﬁtness for surgery.
12. After taking written informed consent the patient was
referred to surgical department for sleeve gastrectomy
(the type of bariatric surgery used in the present study),
it is done by removing part of the stomach along the
greater curvature to leave only 25% of the original size
of the stomach in the form of tube-like structure with
capacity about 150 ml, procedure is simple and done
through laparoscopy without affecting the absorption
of nutrients and vitamins from the intestine [16]. All
patients will receive prophylactic anticoagulant dose of
unfractionated heparin 5000 IU subcutaneously imme-
diately preoperatively and will also be treated with
sequential compression devices. Patients will receive
anticoagulants postoperatively for two weeks. CPAP
was used in the immediate post-operative period and
was used thereafter during sleep in the day and night
until discharge from hospital, morphine-like drugs or
medications that can affect the respiratory center was
avoided during the post-operative period.
Assessment of the effect of bariatric surgery on severe obstructive sleep apnea patients 66313. After operation patients were followed up in the outpa-
tient clinic for any complication of surgery and for the
degree of weight loss.
14. After 12 months of follow up patients were assessed
again for:Tabl
patie
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vital Second time polysomnography was done for new
assessment of the degree of OSA and for titration of
CPAP pressure again if needed.
 Degree of weight loss.
 Body Mass Index.
 Pulmonary function testing.
 Epworth Sleepiness Scale.Statistical analysis
All statistical analyses were conducted using the software
package SPSS 20.0 for Windows (SPSS Inc., Chicago, IL,
USA). Data are presented as frequencies for categorical
variables, and by mean ± standard deviation for numerical
variables. Patients’ data were compared before and after
surgery using dependent T-test, p values less than 0.05 were
considered signiﬁcant.
Results
The study was started with 30 patients having severe OSA and
not tolerating the CPAP therapy, all patients offered the surgi-
cal options, 27 patients accepted and three patients refused the
surgical option and was removed from the study, all the 27
patients had undergone the surgery without complications
but during the period of follow up 5 patients were lost and
did not continue the study. So the study was completed with
22 patients who completed the period of follow up for
12 months. Baseline epidemiologic and anthropometric data
of the 22 patients who completed the study are presented in
Table 1.
From Table 1: the mean age of the patients was
37.2 ± 17.3 years, with 13 male and 9 female patients, the
mean neck circumference of the patients was 38.2 ± 3.6 cm,
baseline body weight was 135.6 ± 17.8 kg m, mean BMI wase 1 Baseline epidemiologic and anthropometric data of
nts.
acter Mean ± SD
of patients 22
in years 37.2 ± 17.3
er: male/female ratio 13/9
circumference in Cm 38.2 ± 3.6
line body weight in kg m 135.6 ± 17.8
mass index (kg/m2) 48.2 ± 7.3
orth Sleepiness Scale (ESS) 16.8 ± 6.8
1% pred. 70.3 ± 3.64
% pred. 69.6 ± 6.5
1/FVC ratio 83.4 ± 2.3
1: forced expiratory volume in the ﬁrst second, FVC: forced
capacity.48.2 ± 7.3 kg m/m2 denoting that all patients were in the
range of morbid obesity, the mean ESS of the patients was
16.8 ± 6.8. Lastly pulmonary functions (PFT) of the studied
group indicated mild restrictive pattern which is mostly due
to obesity as chronic respiratory illness was excluded.
From Table 2 the TST of the studied patient was
358.1 ± 3.5 min with a sleep efﬁciency of 69.4 ± 3.25%,
the percentage of non REM sleep from the TST was
75.3 ± 6.8%, while the percentage of REM sleep from the
TST was 20.4 ± 2.9%, the mean arousal index during sleep
was markedly increased denoting disturbed sleep in these
patients (40.6 ± 7.9/h) which can affect the quality of life,
the total AHI during sleep was 55.8 ± 8.3/h which denotes
that all patients had severe degree of OSA, the lowest oxygen
saturation reached during sleep was 67.2 ± 11.3%, mean
ODI4% was 52.6 ± 6.5/hour of sleep, the mean CPAP pres-
sure titrated for the studied patients was 13.2 ± 2.3 cm H2O.
After surgery patients were followed up for 12 months for
the degree of weight loss and any possible complication of
surgery or recurrence of symptoms of OSA, 2 patients had
complete remission of OSA with the AHI dropping below 5
attacks/hour of sleep while 20 patient still had OSA but to a
lesser degree than before surgery. A comparison of anthropo-
metric and polysomnography data before and after surgery is
presented in Table 3.
Table 3 shows a signiﬁcant decrease in all anthropometric
data of the patients, mean neck circumference dropped from
38.2 ± 3.6 to 32.2 ± 4.6 cm (p= 0.001), mean body weight
dropped from 135.6 ± 17.8 to 101.3 ± 7.6 kg m (p= 0.001),
mean BMI dropped from 48.2 ± 7.3 to 35.9 ± 4.8 kg m/m2
(p= 0.001), consequently this drop was reﬂected on the ESS
which decreased from 16.8 ± 6.8 to 10.2 ± 3.5 (p= 0.001)
and on the pulmonary function parameters which improved
as follows: FEV1% pred. was increased from 70.3 ± 3.64 to
71.5 ± 3.8 (p= 0.04) and FVC% pred. was increased from
69.6 ± 6.5 to 74.2 ± 3.4 (p= 0.02). As regards the
polysomnography data sleep efﬁciency was increased from
69.4 ± 3.25 to 75.4 ± 6.25 (p= 0.04), mean lowest Sao2
during sleep was increased from 67.2 ± 11.3 to 92.2 ± 5.3%
(p= 0.001), mean AHI was decreased from 55.8 ± 8.3 to
12.8 ± 11.3 attacks/hour of sleep (p= 0.001), mean arousal
index was decreased from 40.6 ± 7.9 to 13.6 ± 8.9/hour of
sleep (p= 0.001), mean oxygen desaturation index 4% was
decreased from 52.6 ± 6.5 to 10.6 ± 6.5/hour of sleepTable 2 Baseline polysomnography data of the patients
before surgery.
Character Mean ± SD
Total sleep time (TST) in min. 358.1 ± 3.5
Sleep eﬃciency 69.4 ± 3.25
Non REM sleep time as % from TST 75.3 ± 6.8
REM sleep time as % from TST 20.4 ± 2.9
Arousal index/hour 40.6 ± 7.9
AHI/hour 55.8 ± 8.3
Lowest Sao2 during sleep 67.2 ± 11.3
Oxygen desaturation index 4% 52.6 ± 6.5
CPAP pressure after titration 13.2 ± 2.3 cm H2O
REM: Rapid Eye Movement, AHI: Apnea/Hypopnea Index,
CPAP: continuous positive airway pressure.
Table 3 Anthropometric and polysomnography data before and 12 months after surgery.
Character Before surgery After surgery p value
Neck circumference in Cm 38.2 ± 3.6 32.2 ± 4.6 0.001**
Body weight in kg m 135.6 ± 17.8 101.3 ± 7.6 0.001**
Body mass index (kg/m2) 48.2 ± 7.3 35.9 ± 4.8 0.001**
Epworth Sleepiness Scale (ESS) 16.8 ± 6.8 10.2 ± 4.5 0.001**
PFT
FEV1% pred. 70.3 ± 3.64 71.5 ± 3.8 0.04*
FVC% pred. 69.6 ± 6.5 74.2 ± 3.4 0.02*
FEV1/FVC ratio 83.4 ± 2.3 82.6 ± 1.6 0.06
Total sleep time (TST) in min. 358.1 ± 3.5 360.1 ± 1.5 0.09
Sleep eﬃciency 69.4 ± 3.25 75.4 ± 6.25 0.04*
Non REM sleep time as % from TST 75.3 ± 6.8 74.3 ± 7.8 0.07
REM sleep time as % from TST 20.4 ± 2.9 22.4 ± 1.9 0.06
Arousal index/hour 40.6 ± 7.9 13.6 ± 8.9 0.001**
AHI/hour 55.8 ± 8.3 12.8 ± 11.3 0.001**
Lowest Sao2 during sleep 67.2 ± 11.3 92.2 ± 5.3 0.001
**
Oxygen desaturation index 4% 52.6 ± 6.5 10.6 ± 6.5 0.001**
CPAP pressure after titration 13.2 ± 2.3 cm H2O 8.2 ± 3.9 cm H2O 0.001
**
* Signiﬁcant difference p< 0.05.
** Highly signiﬁcant difference p< 0.01.
Figure 2 Mean AHI before and 12 months after surgery.
664 H. Shaarawy et al.(p= 0.001) and lastly mean CPAP pressure needed to control
OSA was decreased from 13.2 ± 2.3 to 8.2 ± 3.9 cm H2O and
as mentioned before two patients had the AHI below 5 and did
not need the CPAP again (Figs. 1 and 2).
Discussion
The aim of the present study was to assess the effect of baria-
tric surgery on patients with severe OSA, not tolerating CPAP
therapy. This selected group of patients represents a medical
problem as they are not compliant on the CPAP which is the
gold standard therapy and at the same time they have almost
no other option for treatment like mild to moderate cases with
OSA. Alternative options include: oral appliances which
according to the standards and guidelines, its major role for
therapy appears to be the treatment of patients with mild-to-
moderate OSA who cannot tolerate CPAP (and BiPAP) ther-
apy. These devices are relatively unlikely to beneﬁt patients
with severe OSA [17,18]. Sleep surgery, on the other hand,
has poor success rates. When the traditional surgical deﬁnition
(50% reduction in AHI and/or 620) is applied, the pooledFigure 1 Mean body weight before and 12 months after surgery.success rate for phase I procedures (soft palate surgery with
or without adjuvant treatment targeting base of tongue
obstruction) is 55%, but with AHI 610 as a cut-off point,
success rate decreases to 31.5%; and at AHI 65, success is
reduced to 13% [19]. Studies have shown that the success rates
of sleep surgery are lower in patients with an increased BMI
[20,21]. As obesity is highly linked to OSA the only option
for these patients is to lose weight which can help in decreasing
AHI, lowering blood pressure, improving pulmonary function
and arterial blood gas values, improving sleep structure and
snoring, with possible reduction in optimum CPAP pressure
required to control OSA [9–11]. In the present study patients
were instructed to attempt losing weight twice and if failed bar-
iatric surgery was offered as the last option. As is well-known
by anesthesiologists, morbidly obese patients with OSAS
present a formidable challenge throughout the peri-operative
period. Life threatening problems can arise with respect to
tracheal intubation, tracheal extubation, and the provision of
satisfactory postoperative analgesia [22]. Furthermore, the
Assessment of the effect of bariatric surgery on severe obstructive sleep apnea patients 665effect of bariatric surgery on the AHI is difﬁcult to predict. As
the pathogenesis of OSA in obese patients is not just due to
local fatty deposition in the neck resulting in a reduction in
the lumen of the upper airway thereby reducing airﬂow and
inducing airway collapse, but is of a more complex nature,
including factors such as age, sex, skeletal structures, neuro-
muscular, and metabolic function [23–25]. Thus, the pathogen-
esis and relationship of the extent of weight loss with
improvement of OSA needs further investigation. From the
above it is an important issue to put the bariatric surgery as
a treatment option in OSA in the correct place to get the max-
imal beneﬁt with avoidance of side effects of un-necessary
surgery. If there is another option, in the present study we
selected certain group of OSA patients who are not tolerating
the CPAP and cannot lose weight with the normal measures.
The results of the present study were encouraging as all
patients had no complications and weight loss was signiﬁcant
with its effect on the BMI and AHI, 2 patients had complete
cure of OSA and the AHI was below 5/h after 12 months from
surgery, 20 patients still having OSA but to a lesser degree and
in need of less CPAP pressure to control their disease. The
results of our study add more evidence to the effect of bariatric
surgery on severe OSA patients and increase the options of
treatment for those problematic patients who are having severe
OSA and refusing the CPAP machine, although these patients
are more vulnerable to surgical complications; leaving them
without treatment for OSA can lead to many complications
or even sudden death during sleep. The results are in line with
other studies having the same conclusion: Scheuller M, and
Weider D [26] studied the long term effect of bariatric surgery
in 15 morbidly obese patients with severe OSA, they followed
the patients for up to 12 years and they concluded that baria-
tric surgery as a means of treating OSA in the morbidly obese
provides effective long-term reduction in RDI. Bariatric sur-
gery also signiﬁcantly improves minimum oxygen saturation
in morbidly obese patients with OSA. Fritscher LG et al.
[27] studied the impact of bariatric surgery on obstructive sleep
apnea in morbidly obese patients. The study was done on 13
patients with moderate to severe OSA. Patients were followed
up for 18 months. The authors found a marked improvement
in the RDI, mean and minimum oxygen saturation during
sleep and they concluded that: weight loss achieved by baria-
tric surgery is associated with signiﬁcant long-term improve-
ments in obstructive respiratory event, oxygenation and
resolution of daytime somnolence. Rao A et al. [28] studied
the incidence of OSA in severely obese Asian patients and
the effect of bariatric surgery on these patients, 250 obese
patients were evaluated and severe OSA was discovered in
33% of patients while moderate OSA was discovered in 46%
of patients after surgery. Patients were followed up until reach-
ing the target body weight and then evaluated again with
polysomnography. The authors concluded that the incidence
of OSA in Asians undergoing bariatric surgery is high. Rou-
tine sleep studies in Asian patients are justiﬁed. Weight loss
brought about a signiﬁcant improvement in AHI and continu-
ous positive airway pressure requirements. Ravesloot MJ et al.
[29] measured the effect of bariatric surgery on various clinical,
respiratory, and sleep parameters of OSA at two postoperative
intervals at 6 and 12 months respectively. The study was done
on 110 patients and the authors concluded that BS initiates
dramatic improvement and even remission of clinical and sleep
parameters during the ﬁrst 7 months, which continues at aslower rate over the next 10 months. They recommend a
follow-up PSG after surgery to check for residual disease
and if necessary retitration of continuous positive airway
pressure, which may lead to higher treatment compliance.
The present study has 2 main limitations: the ﬁrst limitation
is the small number of patients included and so, we recom-
mend for larger studies on more patients to ensure the effect
of bariatric surgery on these patients. The second limitation
is the short period of follow up, may be with a longer period
of follow up patients can lose more weight and this can
improve the results or more patients can be completely cured
and leave the CPAP. But we chose the period of one year as
it is the period in which occurs most of the excess weight loss
and even if continues it continues at a slower rate which may
not affect the results signiﬁcantly.
Conclusion
Sleeve gastrectomy can be an alternate option of treatment for
severe OSA patients who are not tolerating CPAP and surgery
may cure the disease or at least improve compliance to CPAP
by decreasing the needed pressure to control OSA.
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